Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
06 déc. 2022 07h30 HE
|
BiondVax Pharmaceuticals Ltd.
Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...